Phase II trial of bortezomib [Velcade] in patients with advanced or relapsed lymphoma of the mucosa associated lymphoid tissue (MALT) type
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Bortezomib (Primary)
- Indications Marginal-zone-B-cell-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 02 Jun 2009 Planned number of patients changed from 16 to 16.
- 15 Oct 2006 New trial record.